688366.SH上海证券交易所 · 科创板 STAR
Haohai Biotec 昊海生科
Medical Devices 医疗器械
¥29.91−¥0.49 · −1.61%
Open 开盘
¥30.24
High 最高
¥30.49
Low 最低
¥29.71
Prev Close 昨收
¥30.40
Volume 成交量
40.6万股
Turnover 成交额
¥1,223.6万
Mkt Cap 总市值
¥68亿
P/E 市盈率
44.9×
Recent Activity 近期动态All Filings 全部公告 →
7 significant filings since 30 May 2026: 5 on dividend, 1 on buyback and 1 on legal representative change. The latest, on 14 Sep 2026: 上海市锦天城律师事务所关于上海昊海生物科技股份有限公司差异化权益分派事项的法律意见书.
自 30 May 2026 起有 7 份重大公告：dividend 5 份、buyback 1 份、legal representative change 1 份。最新一份（14 Sep 2026）：上海市锦天城律师事务所关于上海昊海生物科技股份有限公司差异化权益分派事项的法律意见书。
30.0035.0040.0045.0050.00
Volume 成交量
304.0万
Sep 25Dec 25Mar 26Jun 26Sep 26
Overview 概览Deep Report 深度报告Financials 财务Valuation 估值Ownership 股东Analysts 券商Estimates 预测News 动态Events 事件Peers 同业
Company News 公司动态
Everything 全部 224 Filings 公告 121 Unverified Reports 传闻 0 Broker Reports 研报 73 Results and Pre-announcements 业绩 30
Nothing of this kind is held for this company. Filings are held in full from 1 Jan 2026, broker reports from 2 Jan 2017 and results from 9 Apr 2019. 公告自 1 Jan 2026 起完整收录，研报自 2 Jan 2017 起，业绩自 9 Apr 2019 起。